InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Discover the complete record of transactions filed by Semba Charles Pauling. Officer active across 1 company, notably DiaMedica Therapeutics Inc.. In total, 5 disclosures have been recorded. Split: 1 buy · 0 sell. Total volume traded: €46k. History available since 3 January 2023. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Semba Charles Pauling is a declarant linked to DiaMedica Therapeutics Inc. (XNAS) as a Director. He has 5 filings in total, and across the sampled recent filings from 2023-01-03 to 2026-01-06, the reported buy volume is EUR 45622 and the reported sell volume is EUR 0, with the modal transaction nature listed as Attribution.